ARPC1B

protein-coding

actin related protein 2/3 complex subunit 1B, the group of WD repeat domain containing|Actin related protein 2/3 complex subunits

Gene summary

This gene encodes one of seven subunits of the human Arp2/3 protein complex. This subunit is a member of the SOP2 family of proteins and is most similar to the protein encoded by gene ARPC1A. The similarity between these two proteins suggests that they both may function as p41 subunit of the human Arp2/3 complex that has been implicated in the control of actin polymerization in cells. It is possible that the p41 subunit is involved in assembling and maintaining the structure of the Arp2/3 complex. Multiple versions of the p41 subunit may adapt the functions of the complex to different cell types or developmental stages. This protein also has a role in centrosomal homeostasis by being an activator and substrate of the Aurora A kinase. [provided by RefSeq, Mar 2011]

MANE transcript

NM_005720.4

Inheritance

AR

ClinVar variants

P:28U:144B:112

Top phenotype

Immunodeficiency 71 with inflammatory disease and congenital thrombocytopenia

gnomAD constraint

pLI —, LoF o/e 0.34

Max pathogenic AF

—

Genomic locus

chr7:99,374,249-99,394,816

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~20.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

platelet abnormalities with eosinophilia and immune-mediated inflammatory diseaseSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0060583

Submitter: Labcorp Genetics (formerly Invitae)

platelet abnormalities with eosinophilia and immune-mediated inflammatory diseaseDEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0060583

Submitter: ClinGen

ARPC1B was first reported in relation to autosomal recessive Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease in 2017 by Kahr et al. (PMID: 28368018). At least 10 loss of function (indel, deletions, duplications, nonsense) and missense variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of Case Level Data: 12 POINTS Variants in this gene have been reported in at least 10 probands in 4 publications (PMIDs 30254128, 28368018, 27965109, 29127144). Variants in this gene segregated with disease in 2 additional family members. More evidence is available in the literature (PMID: 30771411), but the maximum score for genetic evidence and/or experimental evidence (12 pts.) has been reached. The mechanism for disease is expected to be homozygous loss of function (PMID: 28368018). Summary of Experimental Data: 2 POINTS This gene-disease association is supported by animal models and in vitro functional assays (PMIDs 30254128, 28368018, 27965109, 29127144). However, In summary, the ARPC1B-autosomal recessive Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease gene-disease relationship is definitive. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hemostasis/Thrombosis GCEP on July 22, 2020. (SOP Version 7) Secondary Curation of ARPC1B: SCID/CID GCEP August 12, 2026 ARPC1B deficiency is an autosomal-recessive inborn error of immunity (IEI) caused by biallelic germline mutations in ARPC1B, a hematopoietically-expressed subunit of the actin-nucleating ARP2/3 complex; loss of function impairs branched actin filament formation and cytoskeletal remodeling in leukocytes and platelets. Clinically it presents as a combined immunodeficiency with early-onset recurrent (including viral) infections and thrombocytopenia with small platelets, accompanied by prominent immune dysregulation—eczema/severe dermatitis, allergy, leukocytoclastic vasculitis, and colitis. The characteristic immune phenotype includes T-cell lymphopenia with reduced naïve/CD8⁺ T cells, impaired TCR-driven proliferation and defective immune-synapse formation and cell migration, together with eosinophilia and elevated IgE and IgA. Hematopoietic cell transplantation is currently the only curative option (2019 — PMID: 30662060; 2022 — PMID: 35967303)

platelet abnormalities with eosinophilia and immune-mediated inflammatory diseaseSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0060583

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Immunodeficiency 71 with inflammatory disease and congenital thrombocytopeniaAR

Manifestation: Allergy/Immunology/Infectious; Hematologic

Intervention: Allergy/Immunology/Infectious

Rationale: The condition can involve immunologic abnormalities, including immunodeficiency and vasculitis, and diagnosis may allow preventative measures and early and prompt treatment of infections (for example, with IVIG, immunosuppression, and prophylactic antibiotics); HSCT has been described

Refs: 27965109; 28368018; 29127144; 30254128; 32499645Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ARPC1B variants in ClinVar

9 Conditions Cataloged
not providedTotal: 339
Inborn genetic diseasesTotal: 53
not specifiedTotal: 43
Platelet abnormalities with eosinophilia and immune-mediated inflammatory diseaseTotal: 27
ARPC1B-related disorderTotal: 24
Combined immunodeficiencyTotal: 2
ThrombocytopeniaTotal: 1
Inherited Immunodeficiency DiseasesTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_005720.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
101
clinvar
2
clinvar
105
missense
2
clinvar
1
clinvar
135
clinvar
9
clinvar
147
nonsense
1
clinvar
1
clinvar
2
start loss
0
frameshift
11
clinvar
3
clinvar
2
clinvar
16
splice donor/acceptor (+/-2bp)
4
clinvar
5
clinvar
5
clinvar
14
Total1991441102284

Highest pathogenic variant AF is 0.000025312125

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 94 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_005720.4RefSeqNP_005711.19MANE Select
ENST00000646101.2EnsemblENSP00000496599.19MANE Select
ENST00000414376.6EnsemblENSP00000398620.29Standard
ENST00000417330.6EnsemblENSP00000403324.28Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
arpc1bDanio rerio

Structure: pro-T cell

Quality: decreased amount

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Fc gamma R-mediated phagocytosis - Homo sapiens (human)
  • Salmonella infection - Homo sapiens (human)
  • Endocytosis - Homo sapiens (human)
  • Regulation of actin cytoskeleton - Homo sapiens (human)
  • Bacterial invasion of epithelial cells - Homo sapiens (human)

Biological Process

  • response to estradiol
  • Arp2/3 complex-mediated actin nucleation
  • Fc-gamma receptor signaling pathway involved in phagocytosis
  • response to estrogen
  • ephrin receptor signaling pathway

Molecular Function

  • structural constituent of cytoskeleton
  • protein binding
  • actin filament binding

Cellular Component

  • nucleus
  • cytosol
  • Arp2/3 protein complex
  • focal adhesion
  • actin cytoskeleton

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000451682
Coding exons
9
Length
20553
Individuals with no LoFs
125724
Homozygous LoFs
0
Heterozygous LoFs
24
Defined
125748
p
0.0000954
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.182002530.7910.00001642444
Missense (PolyPhen)5067.4510.74128761
Synonymous0.1491051070.9820.00000769710
Loss of Function2.75720.40.3430.00000107203

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000190.00018rare
Latino/Admixed American0.000120.00012rare
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.000110.00011rare
South Asian0.0000650.000065rare
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation- promoting factor (NPF) (PubMed:11741539, PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:11741539, PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947). {ECO:0000269|PubMed:11741539, ECO:0000269|PubMed:29925947, ECO:0000269|PubMed:9230079}.;
Disease
DISEASE: Platelet abnormalities with eosinophilia and immune- mediated inflammatory disease (PLTEID) [MIM:617718]: An autosomal recessive disorder characterized by platelet abnormalities, vasculitis, eosinophilia, and predisposition to inflammatory diseases. {ECO:0000269|PubMed:28368018}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.129

Intolerance Scores

LoFtool
0.549
RVIS EVS
-0.34
RVIS percentile EVS
30.56

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.822

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.